drugset

drugset / Trial / NCT00143429

Corneal Versus Conjunctival Delivery Using a Delivery Device

NCT00143429 ↗

Phase 2 Withdrawn Viatris Inc.

RandomizedCrossoverSingle-blindTreatment

Summary

Compare the antihypertensive efficacy of three methods for installing Xalatan

Timeline

Start: —
Primary completion: —
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Latanoprost	Small molecule	—	—

Indications